Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study

Abstract

BackgroundIn the Netherlands, there are strong disparities in Chlamydia trachomatis (CT) prevalence between ethnic groups. The current study aims to identify whether socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior may explain differences in CT seroprevalence between ethnic groups.MethodsWe used 2011–2014 baseline data of the HELIUS (HEalthy LIfe in an Urban Setting) study, a multi-ethnic population-based cohort study in Amsterdam, the Netherlands, including participants from Dutch, African Surinamese, South-Asian Surinamese, Ghanaian, Moroccan and Turkish origin. For this analysis, we selected sexually active, heterosexual participants aged 18–34 years old. CT seroprevalence was determined using a multiplex serology assay. The CT seroprevalence ratios between different ethnicities are calculated and adjusted for potential indicators of socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior.ResultsThe study population consisted of 2001 individuals (52.8% female) with a median age of 28 years (IQR 24–31). CT seropositivity differed by ethnicities and ranged from 71.6% (African Surinamese), and 67.9% (Ghanaian) to 31.1% (Turkish). The CT seroprevalence ratio of African Surinamese was 1.72 (95% CI 1.43–2.06) and 1.52 (95% CI 1.16–1.99) of Ghanaian as compared to the Dutch reference group, after adjustment for socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior.ConclusionsIndicators of socioeconomic status, sexual risk behavior, and sexual health seeking behavior could not explain the higher CT seroprevalence among African Surinamese and Ghanaian residents of Amsterdam.Electronic supplementary materialThe online version of this article (10.1186/s12879-018-3533-7) contains supplementary material, which is available to authorized users.

Identification of host-pathogen-disease relationships using a scalable Multiplex Serology platform in UK Biobank

“…For example, the Ct seroprevalence in women was approximately 25% in our study, and thus significantly higher than in other studies using the microimmunofluorescence (MIF) assay or major outer membrane protein (MOMP) peptide ELISA 16,25 . However, our seroprevalence estimate was consistent with recent data from England based on the same antigen (pGP3) in ELISA assays 26 .…”

“…We observed an association between higher socio-economic deprivation and many infectious agents including HSV-1, HSV-2, EBV, CMV, KSHV, HBV, Tg, Hp and Ct (Supplementary Table 11). This was particularly striking for Hp in women where 25…”

Risk Factors for <i>Chlamydia trachomatis</i> Infection and Preterm Birth in Pregnant Japanese Women: Does Chlamydial Infection Cause Preterm Birth?

“…The Chlamydia-positive group had a higher rate of public assistance coverage, smoking during pregnancy, nulliparity, lack of a partner, presence of other STIs, and social high-risk status. Factors associated with chlamydial infection include female sex, younger age (teenagers in particular)(15), high-risk sexual behavior, and a greater number of sexual partners(16), consistent with our results. In addition, we found a higher rate of chlamydial infection among those covered under public assistance.Reports from other countries have found an increased association between lower rates of sexual healthcare-seeking behavior and chlamydial infection and lower socioeconomic status (17).…”

Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study

“…An important limitation of this study is the cross‐sectional character which does not allow disentangling causal associations between H. pylori seropositivity and their determinants. Furthermore, as this study was embedded within other studies, 33,52 the study sample selection was restricted to the ages of 18‐44 years old leaving a narrow age range for research. Our use of a validated multiplex serology assay platform that has been utilized in numerous published seroepidemiological studies of H. pylori may yield different point estimates of seroprevalence than commercial ELISA tests, for instance, yet this will most likely not affect the reported associations and therefore not alter the main conclusions of the manuscript.…”